-
141
DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
Published 2025-02-01Subjects: Get full text
Article -
142
-
143
Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association
Published 2025-03-01Subjects: Get full text
Article -
144
Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
Published 2025-01-01Subjects: Get full text
Article -
145
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
146
The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC
Published 2025-01-01Subjects: Get full text
Article -
147
-
148
High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models
Published 2025-01-01Subjects: Get full text
Article -
149
Case report: Multi-organ injuries induced by tislelizumab
Published 2025-02-01Subjects: Get full text
Article -
150
-
151
Catalysts of change: Immunotherapy's frontier in oral oncology
Published 2024-09-01Subjects: Get full text
Article -
152
Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study
Published 2024-12-01Subjects: Get full text
Article -
153
Sinonasal small-cell carcinoma combined concurrently with small-cell lung carcinoma: case report and literature review
Published 2025-01-01Subjects: Get full text
Article -
154
The role of immunotherapy in the treatment of lip squamous cell carcinoma: A series of six cases and a review of the current literature
Published 2024-06-01Subjects: Get full text
Article -
155
A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
156
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
Published 2025-02-01Subjects: Get full text
Article